Scientists test drug combo to slow cancer growth before surgery
NCT ID NCT04049227
Summary
This small, early study tested two drugs, abemaciclib and letrozole, in patients with endometrial cancer who were already scheduled for a hysterectomy. The goal was to see if taking these drugs for two weeks before surgery could slow cancer cell growth and cause measurable changes in the tumor. Researchers also looked at the safety of this short-term treatment and tried to identify which tumor characteristics might respond best.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL ENDOMETRIOID ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
-
University of Chicago Comprehensive Cancer Center
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.